Cassaday & Co Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Cassaday & Co Wealth Management's VRTX Position: Q2 2026 in Review
Cassaday & Co Wealth Management reduced its Vertex Pharmaceuticals (VRTX) stake by 20% in Q2 2026, selling an estimated $14.2K and leaving 130 shares worth $64.6K. The position accounts for ﹤0.01% of the portfolio, ranked #577.
Cassaday & Co Wealth Management first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. The position peaked at $72.3K in Q1 2026. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Cassaday & Co Wealth Management held 130 shares of Vertex Pharmaceuticals worth $64.6K as of Q2 2026.
- Cassaday & Co Wealth Management sold 32 Vertex Pharmaceuticals shares in Q2 2026, an estimated $14.2K.
- Vertex Pharmaceuticals made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #577 holding.
- Cassaday & Co Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- Cassaday & Co Wealth Management's Vertex Pharmaceuticals position peaked at $72.3K in Q1 2026.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.